Tapewire

Nasdaq · USD

ROIV

Roivant Sciences Ltd.

Export transactions ↓
Tapewire entity
3185
SEC CIK
0001635088
Parsed reports
457

Last 12 months

Inside the activity.

0 purchase rows · 114 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025016
Dec 2025029
Jan 202601
Feb 2026020
Mar 202603
Apr 202603
May 202601
Jun 2026023
Jul 202601
Aug 202609
Sep 202606
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 18, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
SaleCommon Shares 31,801 $37.18 $1,182,361.18
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · nonDerivative · entry 8

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,630,739

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionCommon Shares 31,801 $3.85 $122,433.85
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · nonDerivative · entry 7

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,662,540

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
SaleCommon Shares 105,141 $36.59 $3,847,109.19
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · nonDerivative · entry 6

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,630,739

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $37.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionCommon Shares 105,141 $3.85 $404,792.85
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · nonDerivative · entry 5

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,735,880

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionCommon Shares · Derivative 284,707 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · derivative · entry 10

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,696,479

Underlying: Common Shares · 284,707 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Award of stock options to purchase Common Shares that is fully vested.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
SaleCommon Shares 284,707 $36.25 $10,320,628.75
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · nonDerivative · entry 4

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,630,739

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionCommon Shares 284,707 $3.85 $1,096,121.95
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · nonDerivative · entry 3

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,915,446

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 14, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionCommon Shares · Derivative 243,177 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · derivative · entry 9

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,981,186

Underlying: Common Shares · 243,177 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Award of stock options to purchase Common Shares that is fully vested.

Read SEC document
August 14, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
SaleCommon Shares 243,177 $36.23 $8,810,302.71
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · nonDerivative · entry 2

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,630,739

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document
August 14, 2026 Filed Aug 19, 2026 01:00 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionCommon Shares 243,177 $3.85 $936,231.45
Disclosure

SEC source: 0001140361-26-033637 · form4.xml · nonDerivative · entry 1

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,873,916

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 27, 2026 Filed Jul 30, 2026 01:00 UTC
Venker EricPresident & Immunovant CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001140361-26-030107 · form4.xml · derivative · entry 3

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,044,834

Underlying: Common Stock · 200,000 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares that is fully vested.

Read SEC document
July 27, 2026 Filed Jul 30, 2026 01:00 UTC
Venker EricPresident & Immunovant CEO
SaleCommon Shares 200,000 $34.95 $6,990,000.00
Disclosure

SEC source: 0001140361-26-030107 · form4.xml · nonDerivative · entry 2

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,613,063

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.62 to $35.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document
July 27, 2026 Filed Jul 30, 2026 01:00 UTC
Venker EricPresident & Immunovant CEO
Exercise / conversionCommon Shares 200,000 $3.85 $770,000.00
Disclosure

SEC source: 0001140361-26-030107 · form4.xml · nonDerivative · entry 1

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,813,063

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 17, 2026 Filed Jul 22, 2026 01:00 UTC GrantCommon Shares 543 $0.00 $0.00
Disclosure

SEC source: 0001140361-26-029192 · form4.xml · nonDerivative · entry 1

Epperly Melissa B, · CIK 0001807359 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,017

F1 · shares: Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

F1 · price: Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

Read SEC document
July 17, 2026 Filed Jul 22, 2026 01:00 UTC
Oren IlanDirector
GrantCommon Shares 775 $0.00 $0.00
Disclosure

SEC source: 0001140361-26-029191 · form4.xml · nonDerivative · entry 1

Oren Ilan · CIK 0001643073 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,004

F1 · shares: Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

F1 · price: Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

Read SEC document
July 17, 2026 Filed Jul 22, 2026 01:00 UTC GrantCommon Shares 405 $0.00 $0.00
Disclosure

SEC source: 0001140361-26-029193 · form4.xml · nonDerivative · entry 1

MOMTAZEE JAMES C · CIK 0001209181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,810

F1 · shares: Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

F1 · price: Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

Read SEC document
June 30, 2026 Filed Jul 1, 2026 00:38 UTC SaleCommon Shares 200,000 $35.45 $7,090,000.00
Disclosure

SEC source: 0001193125-26-291172 · ownership.xml · nonDerivative · entry 6

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,748,403

Read SEC document
June 30, 2026 Filed Jul 1, 2026 00:38 UTC SaleCommon Shares 12,380 $35.28 $436,766.40
Disclosure

SEC source: 0001193125-26-291172 · ownership.xml · nonDerivative · entry 5

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 13,689,166

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 30, 2026 Filed Jul 1, 2026 00:30 UTC SaleCommon Shares 12,380 $35.28 $436,766.40
Disclosure

SEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 5

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 13,689,166

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 30, 2026 Filed Jun 30, 2026 23:59 UTC
QVT Financial LPDirector by Deputization
SaleCommon Shares 12,380 $35.28 $436,766.40
Disclosure

SEC source: 0001193125-26-291139 · ownership.xml · nonDerivative · entry 5

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 13,689,166

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 23:00 UTC
Sukhatme MayukhDirector · President & CIO
Tax withholdingCommon Shares 46,878 $35.39 $1,659,012.42
Disclosure

SEC source: 0001635088-26-000075 · wk-form4_1783033200.xml · nonDerivative · entry 1

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,630,739

F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 23:06 UTC
Gline MatthewDirector · CEO
Tax withholdingCommon Shares 76,171 $35.39 $2,695,691.69
Disclosure

SEC source: 0001635088-26-000079 · wk-form4_1783033560.xml · nonDerivative · entry 1

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,659,945

F1 · balance_after: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 23:01 UTC
Torti FrankPresident and Vant Chair
Tax withholdingCommon Shares 40,310 $35.39 $1,426,570.90
Disclosure

SEC source: 0001635088-26-000077 · wk-form4_1783033269.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,536,202

F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 23:03 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001349297-26-000004 · wk-form4_1783033435.xml · derivative · entry 3

Fitzgerald Meghan · CIK 0001349297 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,578

Underlying: Common Stock · 10,000 shares

Expires 2033-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Award of stock options to purchase Common Shares that is fully vested.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 23:03 UTC SaleCommon Shares 10,000 $34.90 $349,000.00
Disclosure

SEC source: 0001349297-26-000004 · wk-form4_1783033435.xml · nonDerivative · entry 2

Fitzgerald Meghan · CIK 0001349297 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,963

Read SEC document
June 30, 2026 Filed Jul 2, 2026 23:03 UTC Exercise / conversionCommon Shares 10,000 $8.80 $88,000.00
Disclosure

SEC source: 0001349297-26-000004 · wk-form4_1783033435.xml · nonDerivative · entry 1

Fitzgerald Meghan · CIK 0001349297 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,963

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 00:38 UTC SaleCommon Shares 600,000 $34.59 $20,754,000.00
Disclosure

SEC source: 0001193125-26-291172 · ownership.xml · nonDerivative · entry 4

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 13,701,546

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 00:38 UTC SaleCommon Shares 200,000 $34.44 $6,888,000.00
Disclosure

SEC source: 0001193125-26-291172 · ownership.xml · nonDerivative · entry 3

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 14,301,546

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 00:30 UTC SaleCommon Shares 600,000 $34.59 $20,754,000.00
Disclosure

SEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 4

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 13,701,546

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 00:30 UTC SaleCommon Shares 200,000 $34.44 $6,888,000.00
Disclosure

SEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 3

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 14,301,546

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 29, 2026 Filed Jun 30, 2026 23:59 UTC
QVT Financial LPDirector by Deputization
SaleCommon Shares 600,000 $34.59 $20,754,000.00
Disclosure

SEC source: 0001193125-26-291139 · ownership.xml · nonDerivative · entry 4

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 13,701,546

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 29, 2026 Filed Jun 30, 2026 23:59 UTC
QVT Financial LPDirector by Deputization
SaleCommon Shares 200,000 $34.44 $6,888,000.00
Disclosure

SEC source: 0001193125-26-291139 · ownership.xml · nonDerivative · entry 3

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 14,301,546

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 22:34 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 17,750 $0.00 Strike: $4.46 $0.00
Disclosure

SEC source: 0001807359-26-000010 · wk-form4_1782945259.xml · derivative · entry 4

Epperly Melissa B, · CIK 0001807359 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 169,166

Underlying: Common Stock · 17,750 shares

Expires 2032-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares that is fully vested.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 22:34 UTC SaleCommon Shares 2,748 $34.71 $95,383.08
Disclosure

SEC source: 0001807359-26-000010 · wk-form4_1782945259.xml · nonDerivative · entry 3

Epperly Melissa B, · CIK 0001807359 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,474

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $34.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 22:34 UTC SaleCommon Shares 15,002 $34.32 $514,868.64
Disclosure

SEC source: 0001807359-26-000010 · wk-form4_1782945259.xml · nonDerivative · entry 2

Epperly Melissa B, · CIK 0001807359 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,222

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.65 to $34.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document
June 29, 2026 Filed Jul 1, 2026 22:34 UTC Exercise / conversionCommon Shares 17,750 $4.46 $79,165.00
Disclosure

SEC source: 0001807359-26-000010 · wk-form4_1782945259.xml · nonDerivative · entry 1

Epperly Melissa B, · CIK 0001807359 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,224

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 26, 2026 Filed Jun 29, 2026 22:23 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001635088-26-000073 · wk-form4_1782771783.xml · derivative · entry 6

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,224,363

Underlying: Common Stock · 500,000 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Award of stock options to purchase Common Shares that is fully vested.

Read SEC document
June 26, 2026 Filed Jun 29, 2026 22:23 UTC
Sukhatme MayukhDirector · President & CIO
SaleCommon Shares 500,000 $34.08 $17,040,000.00
Disclosure

SEC source: 0001635088-26-000073 · wk-form4_1782771783.xml · nonDerivative · entry 4

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,677,617

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document
June 26, 2026 Filed Jun 29, 2026 22:23 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionCommon Shares 500,000 $3.85 $1,925,000.00
Disclosure

SEC source: 0001635088-26-000073 · wk-form4_1782771783.xml · nonDerivative · entry 3

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,177,617

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 26, 2026 Filed Jul 1, 2026 00:38 UTC SaleCommon Shares 325,000 $34.07 $11,072,750.00
Disclosure

SEC source: 0001193125-26-291172 · ownership.xml · nonDerivative · entry 2

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 14,501,546

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 26, 2026 Filed Jul 1, 2026 00:38 UTC SaleCommon Shares 300,783 $33.92 $10,202,559.36
Disclosure

SEC source: 0001193125-26-291172 · ownership.xml · nonDerivative · entry 1

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 14,826,546

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 26, 2026 Filed Jul 1, 2026 00:30 UTC SaleCommon Shares 325,000 $34.07 $11,072,750.00
Disclosure

SEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 2

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 14,501,546

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 26, 2026 Filed Jul 1, 2026 00:30 UTC SaleCommon Shares 300,783 $33.92 $10,202,559.36
Disclosure

SEC source: 0001193125-26-291163 · ownership.xml · nonDerivative · entry 1

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 14,826,546

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 23:59 UTC
QVT Financial LPDirector by Deputization
SaleCommon Shares 325,000 $34.07 $11,072,750.00
Disclosure

SEC source: 0001193125-26-291139 · ownership.xml · nonDerivative · entry 2

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 14,501,546

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 23:59 UTC
QVT Financial LPDirector by Deputization
SaleCommon Shares 300,783 $33.92 $10,202,559.36
Disclosure

SEC source: 0001193125-26-291139 · ownership.xml · nonDerivative · entry 1

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 14,826,546

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 22:23 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001635088-26-000073 · wk-form4_1782771783.xml · derivative · entry 5

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,724,363

Underlying: Common Stock · 500,000 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Award of stock options to purchase Common Shares that is fully vested.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 22:23 UTC
Sukhatme MayukhDirector · President & CIO
SaleCommon Shares 500,000 $34.13 $17,065,000.00
Disclosure

SEC source: 0001635088-26-000073 · wk-form4_1782771783.xml · nonDerivative · entry 2

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,677,617

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 22:23 UTC
Sukhatme MayukhDirector · President & CIO
Exercise / conversionCommon Shares 500,000 $3.85 $1,925,000.00
Disclosure

SEC source: 0001635088-26-000073 · wk-form4_1782771783.xml · nonDerivative · entry 1

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,177,617

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 22:13 UTC
Venker EricPresident & Immunovant CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001635088-26-000071 · wk-form4_1782512028.xml · derivative · entry 4

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,244,834

Underlying: Common Stock · 200,000 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares that is fully vested.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 22:13 UTC
Venker EricPresident & Immunovant CEO
SaleCommon Shares 46,234 $33.51 $1,549,301.34
Disclosure

SEC source: 0001635088-26-000071 · wk-form4_1782512028.xml · nonDerivative · entry 3

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,613,063

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.23 to $33.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.